Ireland
--:--IST
Active, not recruiting Not applicable

Vagal Stimulation in Individuals With Stroke

NCT07822854 · tracked via the Priya Life Science Turkey tracker
Sponsor
Nermin KART
Phase
Not applicable
Started
2025-02-25
Last updated
2026-09-16

Condition(s) studied

StrokeVagus Nerve StimulationMotor FunctionOtonomic FunctionCognitive Function

Investigational drug(s) / intervention(s)

vagus nerve stimulationclassic rehabilitation

vagus nerve stimulation: Manual Vagus Nerve Stimulation (mVNS) Manual vagus nerve stimulation (mVNS) is a non-invasive, accessible, and cost-effective alternative to electrical vagus nerve stimulation (VNS). Unlike invasive methods, mVNS targets key vagal pathways through manual techniques that aim to modulate autonomic function, enhance neuroplasticity, and promote recovery. This study applies mVNS twice a week for eight weeks, using the following techniques: Suboccipital Inhibition Technique: Both hands are placed under the occiput, applying deep, gliding, and progressive pressure for 10 minutes to relax suboccipital muscles. Fourth Ventricle Technique: Hands are positioned under the occiput, applying cephalic traction for 10 minutes to aid autonomic nervous system balance. Diaphragm Release: Hands are placed bilaterally on the anterior lower ribs, applying gentle traction during inspiration and pressure during expiration. Carotid Sinus Massage: Mechanical pressure is applied above the thyroid cartilag

classic rehabilitation: Passive and Active Joint Movements: Applied to maintain joint range of motion and prevent contractures. Muscle Strengthening Exercises: Isometric, isotonic, and resistance exercises are used to strengthen weakened muscle groups. Balance and Gait Training: Supported by proprioceptive exercises and weight-shifting techniques.

Study summary

The aim of this study is to investigate the effects of manual vagus nerve stimulation (VNS) on motor, autonomic, and cognitive functions in individuals with chronic stroke. Additionally, researchers will assess the safety of this treatment. The primary research questions that this study aims to address are as follows:

Does manual vagus nerve stimulation improve motor function in individuals with chronic stroke? Does manual vagus nerve stimulation influence autonomic functions in individuals with chronic stroke? Does manual vagus nerve stimulation accelerate cognitive recovery in individuals with chronic stroke? Researchers will compare the effects of manual vagus nerve stimulation with a standard rehabilitation program.

Participants in the experimental group will receive manual vagus nerve stimulation three times a week for eight weeks, in addition to the standard rehabilitation program. Participants in the control group will receive only the standard rehabilitation program.

Each participant will:

Attend clinical assessments and evaluation tests. Have their motor skills, autonomic function, and cognitive status recorded at the beginning of the treatment and at the end of the eight-week intervention period.

This study will contribute to a better understanding of the potential of manual vagus nerve stimulation as a novel therapeutic approach for individuals with stroke.

Eligibility

Sex
ALL
Min age
45 Years
Max age
70 Years
Healthy volunteers
No
Inclusion Criteria: * Having experienced an ischemic or hemorrhagic stroke * Diagnosed with stroke at least six months prior * No history of multiple stroke episodes * No communication impairments * Ability to read and write Exclusion Criteria: * Presence of hearing loss * Receiving additional treatment alongside rehabilitation * Cardiopulmonary disease * Gastrointestinal disease * History of a recent trauma * Presence of neurological disorders other than stroke * Presence of psychological disorders * History of a condition that could have previously affected cognitive function

Primary outcome measure(s)

  • Fugl-Meyer Motor Assessment Total Score — Baseline and Week 8
    Motor function will be assessed using the Fugl-Meyer Motor Assessment (FMA). The scale evaluates motor recovery of the upper and lower extremities in individuals with stroke. Total scores range from 0 to 100, with higher scores indicating better motor function.

Trial sites (1)

FacilityCityRegionStatus
Nermin Kart Sanliurfa Şanlıurfa
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07822854 on ClinicalTrials.gov ↗ ← All trials in Turkey